FDA applicant
Perfuze, Ltd.
FDA records 11 decisions for Perfuze, Ltd. (Galway, IE) from 2022 to 2026: 11 510(k) clearances. Most are in product codes NRY (Catheter, Thrombus Retriever) and QJP (Catheter, Percutaneous, Neurovasculature). Since 2016 its 510(k)s took a median of 61 days from receipt to decision, against 147 for FDA’s reviews in the same codes and years. Its devices cite 12 predicates, 8 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Perfuze, Ltd.’s devices, and how often a recall has named them.
FDA decisions per year
2in 2025
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2022.
Planning a device like Perfuze, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report